Mercury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 8.30
0.00 (0.00%)
Dec 31, 2025, 2:50 PM CST
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 3.47 billion as of December 31, 2025. Its market cap has decreased by -40.78% in one year.
Market Cap
3.47B
Enterprise Value
3.32B
Revenue
246.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
8.30
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has decreased from 5.10B to 3.47B, a decrease of -31.95%. That is a compound annual growth rate of -11.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.47B | -36.83% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 238.84B |
| PharmaEssentia | 179.19B |
| Lotus Pharmaceutical | 74.95B |
| Heron Neutron Medical | 70.34B |
| Bora Pharmaceuticals Co., LTD. | 60.90B |
| Lin BioScience | 33.13B |
| Lumosa Therapeutics | 31.84B |
| Center Laboratories | 29.26B |